Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[BMP and osteoclastogenesis].

Midori Nakamura1, Nobuyuki Udagawa, Yohei Yamamoto

  • 1Matsumoto Dental University, Department of Biochemistry.

Clinical Calcium
|May 9, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Beyond resorption: targeting osteoclast fusion and polarization to restore balanced bone remodeling.

Frontiers in pharmacology·2026
Same author

Real-world comparison of peripheral neuropathy and treatment delivery between Pola-R-CHP and R-CHOP in DLBCL.

British journal of haematology·2026
Same author

Bilateral eyelid erythema and oedema accompanied by systemic lupus erythematosus and syndrome of inappropriate antidiuretic hormone secretion.

Rheumatology advances in practice·2026
Same author

Clinical Images: Marked edema of the left lower leg caused by IgG4-related retroperitoneal fibrosis accompanied by double inferior vena cava.

ACR open rheumatology·2026
Same author

Clinical-grade autonomous cytopathology through whole-slide edge tomography.

Nature·2026
Same author

Perforated Small Intestinal Diffuse Large B-Cell Lymphoma Successfully Managed With Surgical Resection and Staged Introduction of Polatuzumab Vedotin-Based Chemotherapy.

Journal of medical cases·2026

Bone morphogenetic protein-2 (BMP-2) significantly boosts osteoclast formation and survival, working with receptor activator of nuclear factor-kappaB ligand (RANKL) from osteoblasts. Osteoblasts provide a crucial environment for RANKL to drive bone cell development.

Area of Science:

  • Cell biology
  • Bone biology
  • Biochemistry

Context:

  • Osteoclastogenesis is essential for bone remodeling and is tightly regulated.
  • Receptor activator of nuclear factor-kappaB ligand (RANKL) is a key mediator of osteoclast formation.
  • Osteoblasts play a critical role in providing the microenvironment for osteoclastogenesis.

Purpose:

  • To investigate the role of Bone Morphogenetic Protein-2 (BMP-2) in osteoclast differentiation and survival.
  • To elucidate the interplay between BMP-2, RANKL, and osteoblasts in regulating osteoclastogenesis.

Summary:

  • Bone morphogenetic protein-2 (BMP-2) was found to markedly enhance osteoclast differentiation and survival.
  • This enhancement was supported by the action of receptor activator of nuclear factor-kappaB ligand (RANKL).

Related Experiment Videos

  • RANKL, expressed by osteoblasts, is a requirement for osteoclastogenesis, with osteoblasts providing the critical microenvironment for RANKL's action.

    • Impact:

    • This study highlights BMP-2 as a significant factor influencing osteoclast behavior.
    • Understanding this pathway could lead to new therapeutic strategies for bone diseases.
    • The findings underscore the importance of the osteoblast-osteoclast cross-talk in bone homeostasis.